Tools and technologies enabling healthcare

2 known investors

MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy. The platform combines scalable bioprocessing with analytics and data tools to increase access to these therapies.